Leone Patterson
Director Financiero/CFO en TENAYA THERAPEUTICS, INC. .
Fortuna: 130 680 $ al 30/04/2024
Perfil
Leone D.
Patterson currently works at Oxford Biomedica Plc, as Independent Non-Executive Director from 2023, Nkarta, Inc., as Independent Director from 2020, and Tenaya Therapeutics, Inc., as Chief Financial & Business Officer from 2021.
Ms. Patterson also formerly worked at Eliem Therapeutics, Inc., as Independent Director from 2021 to 2023, Chiron Corp., as Vice President & Corporate Controller from 1999 to 2006, Exelixis, Inc., as Vice President-Finance from 2007 to 2010, KPMG LLP, as Senior Manager from 1989 to 1999, Novartis AG, as VP-Global Business Planning & Analysis from 2006 to 2007, NetApp, Inc., as Vice President & Global Corporate Controller from 2010 to 2012, Transcept Pharma, Inc., as Chief Financial Officer & Vice President from 2012 to 2014, Diadexus, Inc., as Chief Financial Officer from 2015 to 2016, and Adverum Biotechnologies, Inc., as President, Chief Financial & Accounting Officer in 2021.
Ms. Patterson received her undergraduate degree from Chapman University and Masters Business Admin degree in 2008 from St. Mary's College (Indiana).
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2024 | 20 755 ( 0.03% ) | 87 586 $ | 30/04/2024 | |
OXFORD BIOMEDICA PLC
0.01% | 26/09/2023 | 12 447 ( 0.01% ) | 43 094 $ | 30/04/2024 |
NKARTA, INC.
-.--% | 15/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Leone Patterson
| Empresas | Cargo | Inicio |
|---|---|---|
| NKARTA, INC. | Director/Miembro de la Junta | 27/04/2020 |
| TENAYA THERAPEUTICS, INC. | Director Financiero/CFO | 01/06/2021 |
| OXFORD BIOMEDICA PLC | Director/Miembro de la Junta | 01/05/2023 |
Antiguos cargos conocidos de Leone Patterson.
| Empresas | Cargo | Fin |
|---|---|---|
| ELIEM THERAPEUTICS, INC. | Director/Miembro de la Junta | 19/01/2023 |
| ADVERUM BIOTECHNOLOGIES, INC. | Director Ejecutivo | 15/06/2020 |
| DIADEXUS, INC. | Director Financiero/CFO | 01/06/2016 |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Director Financiero/CFO | 30/10/2014 |
| NETAPP, INC. | Comptroller/Controller/Auditor | 01/06/2012 |
Formación de Leone Patterson.
| Chapman University | Undergraduate Degree |
| St. Mary's College (Indiana) | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 8 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| NETAPP, INC. | Electronic Technology |
| EXELIXIS, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| NKARTA, INC. | Health Technology |
| ELIEM THERAPEUTICS, INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| OXFORD BIOMEDICA PLC | Health Technology |
| Empresas privadas | 4 |
|---|---|
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Health Technology |
Diadexus, Inc.
 Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
- Bolsa de valores
- Insiders
- Leone Patterson